Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- University of Texas Southwestern Medical Center
- Study ID
- NCT07183644
- Status
- Recruiting
Conditions
- Port Wine Stains
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Months - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Pulse Dye laser — DEVICEPulse Dye Laser (PDL) standard settings. This is the same procedure children would receive as standard of care if these individuals were not participating in this study. The surgeon will perform 1 pass with the PDL over the area of the Port wine birthmark (PWB).
- Pulse Dye Laser (PDL) pulse width stacking — DEVICEThis procedure is used for some patients as standard of care depending on the severity and depth of the lesion. The surgeon will perform 3 passes with the PDL over the PWB, gradually increasing the pulse duration with each pass to effectively target both superficial and deeper blood vessels.
- Pulse Dye Laser (PDL) followed by Nd:YAG (Neodymium-doped Yttrium Aluminum Garnet laser) laser. — DEVICEThe combination of these two lasers is one of the investigational treatments. The surgeon will perform 1 pass per laser over the PWB. The 1st pass will be with the PDL to target the blood vessels closer to the top of the skin, followed by a 2nd pass with the Nd:YAG laser to target the blood vessels that deeper in the skin.
- IPL (Intense Pulsed Light) followed by Pulse Dye Laser (PDL) — DEVICEThe surgeon will perform 1 pass with the IPL followed by 1 pass with the PDL over the PWB
- Cupping followed by Pulse Dye Laser (PDL) — DEVICEThe combination of these modalities is one of the experimental procedures. The surgeon will place a small suction cup over the PWB target region of the PDL for a few seconds to stop the blood flow and accumulate the blood in that spot. The PDL treatment will then quickly proceed. Since the PDL targets red blood cells, it will allow the laser to target the pooled blood in the abnormal blood vessels better.
Study Details
In this study the investigators aim to optimize Port-Wine-Birthmark (PBW) laser therapy in children in order to reduce the number of laser treatments required for clearance and improve outcomes for refractory cases. This approach also seeks to reduce the frequency with which children require general anesthesia for treatment.
Key Dates
- Start date
- Jul 31, 2026
- Status verified
- May 2026
- Primary completion
- Sep 30, 2028
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Active Comparator: All patientsEvery patient will receive the 5 treatment modalities in their first laser treatment after enrollment in the study. * At 5-7 weeks follow-up visit after the procedure, if no treatment modality is better than the other, then the surgeon will repeat the procedure with the 5 modalities, and the subject will have a 2nd follow-up appointment 5-7 weeks later. Continue treatment with 5 modalities and appropriate follow-up until Port Wine Birthmark (PWB) clearance, or, * If any modality is seen to give best results at the first follow-up visit (5-7 weeks after the first procedure), then the next treatment will be only with that modality and will continue to have treatments with this modality and follow-up appointments (5-7 weeks after procedure) according to standard of care timelines for PWBs until the treatment is not improving the PWB anymore or until the PWB is no longer visible.
Primary Outcome Measure
Change in Port Wine Birthmark (PWB) color in participants - Pre Operative [ Time Frame: Baseline ]
Central Contacts
- James R Seaward, MD214 456 5250
- Lauren Bailey, MS
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Medical Center | Dallas | Texas | 75207 | |
| Children's Medical Center | Plano | Texas | 75024 |
Find similar trials in Dallas, TX
Related Studies
- Rapamycin Dose-Ranging Efficacy Study in Port Wine StainsPHASE2 · Not Yet Recruiting · AFT Pharmaceuticals, Ltd. · Corpus Christi, Texas